BCHE and Alzheimer disease: Beneficial anti-AD multi-target profiles have been reported for cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties (49–58) [89], CNSL-derived HDAC inhibitors 59–62 [91], and CNSL-derived compounds-tacrine hybrids (63–75) [94].